TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Conference Poster Year : 2018

Dates and versions

inserm-03950185 , version 1 (21-01-2023)

Identifiers

Cite

Giulia Tueur, Virginie Eclache, Grégory Lazarian, Carole Fleury, Rémi Letestu, et al.. TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group. SOHO, Sep 2018, Houston (Texas), United States. 18, pp.S218, 2018, ⟨10.1016/j.clml.2018.07.084⟩. ⟨inserm-03950185⟩
3 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More